Literature DB >> 3263225

AIDS as immune system activation: a model for pathogenesis.

M S Ascher1, H W Sheppard.   

Abstract

Epidemiological evidence has implicated the human immunodeficiency virus (HIV) as the etiological agent of the acquired immunodeficiency syndrome (AIDS) (Barré-Sinoussi et al., 1983; Sarngadharan et al., 1984; Kitchen et al., 1984; Levy et al., 1984). Primary infection with HIV is accompanied by an acute flu-like illness followed by a relatively long period of asymptomatic infection, the delayed appearance of lymphadenopathy and a progressive decline in immune responsiveness. Eventually, significant reduction in T4 cell number occurs along with susceptibility to a variety of opportunistic infections. It is generally accepted that this lymphotropic retrovirus causes the depletion of the helper class of T lymphocytes (T4) by direct cytopathic effects and/or the induction of autoimmune killing of T cells (Fauci, 1987). Few objections have been raised to this model despite abundant experimental evidence that viraemia and the number of infected T cells are limited and constant throughout disease progression (Levy et al., 1985; Shaw et al., 1984; Harper et al., 1986; Duesberg, 1987). We believe that the current model for HIV-induced pathology is unsatisfactory. A hypothesis is advanced in which progressive immunodeficiency is caused by indirect mechanisms without widespread T cell infection, direct virus-mediated cytopathic effects, or autoimmunity. We propose that the latency of AIDS is not due to delayed viral expression and growth but rather to the accumulation of insults to an immune system with abnormal regulatory mechanisms induced by HIV infection of macrophages.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3263225      PMCID: PMC1541594     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  20 in total

1.  Homograft sensitivity. An expression of the immunologic origins and consequences of individuality.

Authors:  H S LAWRENCE
Journal:  Physiol Rev       Date:  1959-10       Impact factor: 37.312

2.  Detection of lymphocytes expressing human T-lymphotropic virus type III in lymph nodes and peripheral blood from infected individuals by in situ hybridization.

Authors:  M E Harper; L M Marselle; R C Gallo; F Wong-Staal
Journal:  Proc Natl Acad Sci U S A       Date:  1986-02       Impact factor: 11.205

3.  Antibodies reactive with human T-lymphotropic retroviruses (HTLV-III) in the serum of patients with AIDS.

Authors:  M G Sarngadharan; M Popovic; L Bruch; J Schüpbach; R C Gallo
Journal:  Science       Date:  1984-05-04       Impact factor: 47.728

4.  Aetiology of AIDS--antibodies to human T-cell leukaemia virus (type III) in haemophiliacs.

Authors:  L W Kitchen; F Barin; J L Sullivan; M F McLane; D B Brettler; P H Levine; M Essex
Journal:  Nature       Date:  1984 Nov 22-28       Impact factor: 49.962

5.  Molecular characterization of human T-cell leukemia (lymphotropic) virus type III in the acquired immune deficiency syndrome.

Authors:  G M Shaw; B H Hahn; S K Arya; J E Groopman; R C Gallo; F Wong-Staal
Journal:  Science       Date:  1984-12-07       Impact factor: 47.728

6.  Quantification of antigen-reactive cells among human T lymphocytes.

Authors:  M H van Oers; J Pinkster; W P Zeijlemaker
Journal:  Eur J Immunol       Date:  1978-07       Impact factor: 5.532

7.  Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS).

Authors:  F Barré-Sinoussi; J C Chermann; F Rey; M T Nugeyre; S Chamaret; J Gruest; C Dauguet; C Axler-Blin; F Vézinet-Brun; C Rouzioux; W Rozenbaum; L Montagnier
Journal:  Science       Date:  1983-05-20       Impact factor: 47.728

Review 8.  Infection by the retrovirus associated with the acquired immunodeficiency syndrome. Clinical, biological, and molecular features.

Authors:  J A Levy; L S Kaminsky; W J Morrow; K Steimer; P Luciw; D Dina; J Hoxie; L Oshiro
Journal:  Ann Intern Med       Date:  1985-11       Impact factor: 25.391

9.  Isolation of lymphocytopathic retroviruses from San Francisco patients with AIDS.

Authors:  J A Levy; A D Hoffman; S M Kramer; J A Landis; J M Shimabukuro; L S Oshiro
Journal:  Science       Date:  1984-08-24       Impact factor: 47.728

10.  The major histocompatibility complex-restricted antigen receptor on T cells. II. Role of the L3T4 product.

Authors:  P Marrack; R Endres; R Shimonkevitz; A Zlotnik; D Dialynas; F Fitch; J Kappler
Journal:  J Exp Med       Date:  1983-10-01       Impact factor: 14.307

View more
  34 in total

Review 1.  HIV-1 immunopathogenesis in humanized mouse models.

Authors:  Liguo Zhang; Lishan Su
Journal:  Cell Mol Immunol       Date:  2012-04-16       Impact factor: 11.530

Review 2.  The role of cytokines in the pathogenesis and treatment of HIV infection.

Authors:  Marta Catalfamo; Cecile Le Saout; H Clifford Lane
Journal:  Cytokine Growth Factor Rev       Date:  2012-06-26       Impact factor: 7.638

3.  Spontaneous release of interferon as a predictor of clinical evolution in HIV-positive subjects.

Authors:  A Biglino; A Surbone; F Lipani; N Cappello; B Forno; A M Pollono; M Busso; A Pugliese
Journal:  Infection       Date:  1991 Jan-Feb       Impact factor: 3.553

Review 4.  Role of immune activation in HIV pathogenesis.

Authors:  Peter W Hunt
Journal:  Curr HIV/AIDS Rep       Date:  2007-02       Impact factor: 5.071

Review 5.  Immune activation in the context of HIV infection.

Authors:  Z Bentwich; A Kalinkovich; Z Weisman; Z Grossman
Journal:  Clin Exp Immunol       Date:  1998-01       Impact factor: 4.330

Review 6.  Generalized immune activation and innate immune responses in simian immunodeficiency virus infection.

Authors:  Steven E Bosinger; Donald L Sodora; Guido Silvestri
Journal:  Curr Opin HIV AIDS       Date:  2011-09       Impact factor: 4.283

7.  B-lymphocyte dysfunction in chronic HIV-1 infection does not prevent cross-clade neutralization breadth.

Authors:  Saikat Boliar; Megan K Murphy; T Cameron Tran; Diane G Carnathan; Wendy S Armstrong; Guido Silvestri; Cynthia A Derdeyn
Journal:  J Virol       Date:  2012-05-23       Impact factor: 5.103

Review 8.  Chronic immune activation associated with chronic helminthic and human immunodeficiency virus infections: role of hyporesponsiveness and anergy.

Authors:  Gadi Borkow; Zvi Bentwich
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

9.  Expression of interleukin 2 receptors by monocytes from patients with acquired immunodeficiency syndrome and induction of monocyte interleukin 2 receptors by human immunodeficiency virus in vitro.

Authors:  J B Allen; N McCartney-Francis; P D Smith; G Simon; S Gartner; L M Wahl; M Popovic; S M Wahl
Journal:  J Clin Invest       Date:  1990-01       Impact factor: 14.808

Review 10.  Oral complications of HIV disease.

Authors:  Jair C Leao; Camila M B Ribeiro; Alessandra A T Carvalho; Cristina Frezzini; Stephen Porter
Journal:  Clinics (Sao Paulo)       Date:  2009-05       Impact factor: 2.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.